Search - tctmd.com

Displaying 521 - 540 of 624

Sort: Relevancy | Date

News Daily News

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Yael L. Maxwell

April 11, 2018

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Todd Neale

April 11, 2018

News Daily News

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Michael O'Riordan

April 10, 2018

News Daily News

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Shelley Wood

April 06, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

Michael O'Riordan

March 02, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

Shelley Wood

February 01, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

Advertisement

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

Outrunning Your Genes: Exercise Offsets CVD Events Among High-Risk Subjects

Costs of Atherosclerotic CVD Cripple Low-Income Families, Even With Insurance

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

TCTMD’s Top 10 Most Popular Stories for January 2018

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content